NCT02500407
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT02500407
Title A Safety, Efficacy and Pharmacokinetic Study of BTCT4465A (Mosunetuzumab) as a Single Agent and Combined With Atezolizumab in Non-Hodgkin's Lymphoma (NHL) and Chronic Lymphocytic Leukemia (CLL)
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors Genentech, Inc.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | GBR | ESP | DEU | CAN | AUS

Facility Status City State Zip Country Details
University of California San Diego Moores Cancer Center La Jolla California 92093-0698 United States Details
Sansum Medical Clinic, Inc. Santa Barbara California 93105 United States Details
Rocky Mountain Cancer Center Denver Colorado 80218 United States Details
Yale University School Of Medicine New Haven Connecticut 06510 United States Details
Hackensack University Medical Center Hackensack New Jersey 07601 United States Details
Memorial Sloan Kettering Bergen Montvale New Jersey 07645 United States Details
Memorial Sloan Kettering Cancer Center - Commack Commack New York 11725 United States Details
Memorial Sloan Kettering Cancer Center at Westchester Harrison New York 10604 United States Details
New York Uni Medical Center New York New York 10016 United States Details
Willamette Valley Cancer Insitute and Research Center Springfield Oregon 97477 United States Details
University of Pennsylvania Philadelphia Pennsylvania 19103 United States Details
MD Anderson Cancer Center Houston Texas 77030 United States Details
St Vincent's Hospital Sydney Darlinghurst New South Wales 2010 Australia Details
Icon Cancer Care South Brisbane South Brisbane Queensland 4101 Australia Details
Princess Alexandra Hospital Woolloongabba Queensland 4102 Australia Details
Royal Adelaide Hospital Adelaide South Australia 5000 Australia Details
St. Vincent's Hospital Melbourne Fitzroy South Australia 3065 Australia Details
Royal Hobart Hospital Hobart Tasmania 7000 Australia Details
Monash Health Clinical Trial Pharmacy department Clayton Victoria 3168 Australia Details
The Perth Blood Institute Nedlands Western Australia 6009 Australia Details
Princess Margaret Hospital Toronto Ontario M5G 2M9 Canada Details
Jewish General Hospital Montreal Quebec H3T 1E2 Canada Details
Universitatsklinikum Koln Cologne 50931 Germany Details
Universitätsklinikum Heidelberg Heidelberg 69120 Germany Details
Universitaetsmedizin der Johannes Gutenberg-Universitaet Mainz Mainz 55101 Germany Details
Klinikum der Universität München, Campus Großhadern München 83177 Germany Details
Seoul National University Hospital Seoul 03080 South Korea Details
Samsung Medical Center Seoul 06351 South Korea Details
Clínica Universidad de Navarra Pamplona Navarre 31008 Spain Details
Hospital Universitario Vall d Hebron Barcelona 08035 Spain Details
Hospital Universitario La Paz Madrid 280146 Spain Details
Complejo Asistencial Universitario de Salamanca Salamanca 37007 Spain Details
Barts Cancer Institute London EC1A 7BE United Kingdom Details
The Christie NHS Foundation Trust Manchester M20 4BX United Kingdom Details
Royal Marsden Hospital;Institute of Cancer Research Sutton SM2 5PT United Kingdom Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field